Peter Powchik
Keine laufenden Positionen mehr
Vermögen: 27 329 $ am 30.04.2024
Karriereverlauf von Peter Powchik
Ehemalige bekannte Positionen von Peter Powchik
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VAXXINITY, INC. | Direktor/Vorstandsmitglied | 31.03.2022 | 31.03.2024 |
Technik-/Wissenschafts-/F&E-Leiter | 01.10.2023 | 31.03.2024 | |
Corporate Officer/Principal | 01.10.2023 | 31.03.2024 | |
REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2006 | 01.01.2018 |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2005 | 01.10.2006 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2001 | 01.05.2005 |
PFIZER, INC. | Corporate Officer/Principal | 01.04.2001 | 01.04.2001 |
Chugai Pharma USA, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Peter Powchik
New York University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Distribution Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
REGENERON PHARMACEUTICALS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
VAXXINITY, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Distribution Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Chugai Pharma USA, Inc. |
- Börse
- Insiders
- Peter Powchik
- Erfahrung